Detailed Information

Research Field/Keywords for Research Field

• Hematology

Education

• 1984/03, Graduated
• 1984/09, Doctor Course, Unfinished course

Employment Experience

• 1984/10 - 1986/05
• 1986/05 - 1986/05
• 1986/06 - 1987/05
• 1987/06 - 1988/05
• 1988/06 - 1991/05
• 1991/06 - 1992/09
• 1992/10 - 1993/09
• 1993/10 - 1999/09
• 1999/10 - 2003/07 Research Associate
• 2003/08 - 2003/09 Associate Professor
• 2003/10 - 2007/03 Associate Professor, Medicine, Faculty of Medicine, Saga University
• 2007/04 - 2009/02 Associate Professor, Medicine, Faculty of Medicine, Saga University
• 2009/03 - 2013/07 Associate Professor, University Hospital, Faculty of Medicine, Saga University
• 2013/08 -  *  Professor, Medicine, Faculty of Medicine, Saga University
• 2015/04 -  *  University Hospital, Faculty of Medicine, Saga University
• 2015/04 -  *  University Hospital, Faculty of Medicine, Saga University

Field of Specialization

• Hematology, Virology

Research Topics and Results

• Cancer progression by the okadaic acid class of tumor promoters and endogenous protein inhibitors of PP2A, SET and CIP2A  2023/09
• Cancer progression by the okadaic acid class of tumor promoters and endogenous protein inhibitors of PP2A, SET and CIP2A 2023/09
• HTLV-1 cell-free DNA in plasma as a potential biomarker in HTLV-1 carriers and adult T-cell leukemia-lymphoma 2023/05
• Dual targeting of aberrant DNA and histone methylation synergistically suppresses tumor cell growth in ATL 2023/04
• Usefulness of blood biomarkers for predicting venous thromboembolism in Japanese patients with cancer 2023/03
• Originals EFFICACY AND INDICATION OF CRYOPRECIPITATE PLASMA FOR PATIENTS RECEIVING CRYOPRECIPITATE IN A SINGLE INSTITUTION 2023/02
• Management system of home transfusion in Japan: A nationwide survey in 2019 2023/01
• Anti-cancer effect of afatinib, dual inhibitor of HER2 and EGFR, on novel mutation HER2 E401G in models of patient-derived cancer 2023/01
• Correlation of strain classification with IR Biotyper and molecular epidemiological method of Pseudomonas aeruginosa 2022/10
• Cytological Comparison between Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma by Image Analysis Software Using Touch Smear Samples of Surgically Resected Specimens  2022/05
• Clinical utility of comprehensive genomic profiling in Japan: Result of PROFILE-F study  2022/03
• Integrated approach to functional analysis of an ERBB2 variant of unknown significance detected by a cancer gene panel test  2022/02
• P-1030.Biological significance of pyrimidine metabolism enzyme UCK2 of HTLV-1-infected cells in ATL leukemogenesis 2022
• HTLV-1 infection promotes excessive T cell activation and transformation into adult T cell leukemia/lymphoma 2021/12
• Correlation of Strain Classification with IR Biotyper and Molecular Epidemiological Method of Pseudomonas aeruginosa 2021/12
• Effect of skin-capsular distance on controlled attenuation parameter for diagnosing liver steatosis in patients with nonalcoholic fatty liver disease  2021/08
• Monitoring of tumor cells by flow cytometry permits rapid evaluation of disease progression in monomorphic epitheliotropic intestinal T-cell lymphoma 2021/07
• Technical Lecture Development and clinical use of an application for management of drug holidays in perioperative periods 2021/06
• ALDH2 polymorphism rs671 is a predictor of PD-1/PD-L1 inhibitor efficacy against thoracic malignancies  2021/05
• Role of TNF-α-Inducing Protein Secreted by Helicobacter pylori as a Tumor Promoter in Gastric Cancer and Emerging Preventive Strategies  2021/03
• Clinical significance of soluble CADM1 as a novel marker for adult T-cell leukemia/lymphoma 2021/02
• Rapid detection method of carbapenemase-producing Enterobacteriaceae by MALDI-TOF MS with imipenem/cilastatin (KB) disc and zinc sulfate solution 2021/02
• Diagnostic Accuracy of FibroScan and Factors Affecting Measurements 2020/11
• Targeting aberrant DNA hypermethylation as a driver of ATL leukemogenesis by using the new oral demethylating agent OR-2100 2020/08
• Development of Continuous Validation Model on Standard Codes Mapping for Multi-Institutional Collaborative Data-Driven Medical Study 2020/08
• A patient with antibody against low-frequency red blood cell antigen Co^b 2020/07
• Origin of circulating free DNA in patients with lung cancer 2020/07
• Diagnostic accuracy of FibroScan-AST score to identify non-alcoholic steatohepatitis with significant activity and fibrosis in Japanese patients with non-alcoholic fatty liver disease: Comparison between M and XL probes 2020/07
• Development of an application for management of drug holidays in perioperative periods 2020/05
• Development and Evaluation of Screening Culture Medium for Detection of Drug-Resistant Gram Negative Rods Containing Stealth Type CPE 2020/03
• Clinical impact of the CONUT score in patients with multiple myeloma 2020/01
• POSITIVE RATE OF BLOOD PRODUCTS IN THE IRREGULAR ANTIBODY SCREENING TEST AND THE SIGNIFICANCE OF MINOR CROSSMATCHING IN THE CROSSMATCH TEST 2019/12
• Establishment of the MID‐NET® medical information database network as a reliable and valuable database for drug safety assessments in Japan 2019/10
• Primary Chest Wall MYC/BCL6 Double-hit Lymphoma with t (3;7) (q27;p12) and t (8;14) (q24;q32) Translocations. 2019/07
• Meeting report of the 14th Japan-Korea joint symposium on cancer and aging research: current status of translational research and approaches to precision medicine.  2019/05
• The utilization and challenges of Japan's MID‐NET® medical information database network in postmarketing drug safety assessments: A summary of pilot pharmacoepidemiological studies 2019/05
• Clinical impact of the CONUT score and mogamulizumab in adult T cell leukemia/lymphoma 2019/02
• Acute myeloid leukemia with t (19;21)(q13;q22) and marked eosinophilia 2019/01
• Characteristics of circulating tumor DNA in lung cancer patients.  2019
• AnalysisofanovelvariantofHER2detectedbyclinicalsequencingin cancerofunknownprimary. 2019
• Incidence of aspiration pneumonia during hospitalization in Japanese hospitalized cases did not increase whereas concern factors were exacerbated in a time-dependent manner: analysis of Diagnosis Procedure Combination (DPC) data. 2018
• Differentiated embryo chondrocyte plays a crucial role in DNA damage response via transcriptional regulation under hypoxic conditions. 2018
• Automated DNA extraction using cellulose magnetic beads can improve EGFR point mutation detection with liquid biopsy by efficiently recovering short and long DNA fragments. 2018
• Investigation of appropriate pre-analytical procedure for circulating free DNA from liquid biopsy. 2018
• Identification of the BRAF V600E mutation in Japanese patients with hairy cell leukemia and related diseases using a quenching probe method. 2018
• Synchronous mantle cell lymphoma and lung adenocarcinoma presenting in a pleural effusion: A rare tumour combination and a potential pitfall of cytodiagnosis. 2018
• Community-acquired Disseminated Exophiala dermatitidis Mycosis with Necrotizing Fasciitis in Chronic Graft-versus-host Disease.  2018
• The concept of the okadaic acid class of tumor promoters is revived in endogenous protein inhibitors of protein phosphatase 2A, SET and CIP2A, in human cancers. 2018
• Cancer Prevention with Green Tea and Its Principal Constituent, EGCG: from Early Investigations to Current Focus on Human Cancer Stem Cells 2018
• Investigation of origin of circulating free DNA: Is exosomal DNA the carrier? 2018
• Characteristics of circulating tumor DNA in lung cancer patients. 2018
• Comprehensive approach for eradication of Adult T-cell Leukemia-　Lymphoma in Japan - prevention, translational research and clinical approach-  2018
• DEC plays a crucial role in DNA damage response via transcriptional regulation under hypoxic conditions 2018
• Investigation of origin of circulating free DNA: Is EV the carrier? 2018
• Characteristics of circulating tumor DNA in lung cancer patients.  2018
• Characteristics of circulating free DNA in lung cancer patients.  2018
• Investigation of origin of circulating free DNA: Are extracellular vesicles the carrier? 2018
• Analysis of a novel mutation of ERBB2 in cancer of unknown primary 2018
• Abnormal CpG methylation around the transcription start sites as therapeutic target in adult-T cell leukemia-lymphoma 2018
• CSCs in mouse skin carcinogenesis and inhibitory effects of EGCG on expression of stemness markers in human CSCs 2018
• Functional analysis of Discoidin domain receptor 2 mutation and expression in squamous cell lung cancer. 2017
• Plasma T790M and HGF as potential predictive markers for EGFR-TKI re-challenge. 2017
• Mutation profile of B-raf gene analyzed by fully automated system and clinical features in Japanese melanoma patients 2017
• Epigenetic regulation of the genes in indolent types of adult T-cell leukemia/lymphoma analyzed by comprehensive DNA methylation array 2017
• Automatic DNA extraction system can improve the EGFR point mutation detection rate of liquid biopsy.  2017
• Characteristics of cell free DNA in lung cancer patients.  2017
• DNA extraction method using cellulose magnetic beads can improve the EGFR mutation detection rate. 2017
• Torin2 potentiates anti-cancer effects for adult T-cell leukemia/lymphoma by inhibiting mammalian target of rapamycin. 2016
• Reversible Liver Steatosis Induced by Chemotherapy of Mixed-phenotype Acute Leukemia. 2016
• Acute myeloid leukemia with t(3;8)(q26;q24) complicated by diabetes insipidus.  2016
• Erratum to "Expression of Mina53, a novel c-Myc target gene, is a favorable prognostic marker in early stage lung cancer" [Lung Cancer 69/2 (2010) 232-238]. 2016
• Notch3 is regulated by Hypoxia-inducible factor-1a in hypoxia 2016
• Detection of left ventricular hypertrophy using electrocardiography in cases preidentified by echocardiography 2016
• Comparison of phage open reading flame typing and rep-PCR method for genetic typing of multi-drug resistant Pseudomonas aeruginosa strains 2016
• Functional analysis of Discoidin Domain Receptor 2(DDR2) mutation and expression in squamous cell lung cancer 2016
• Immunological responses after massive blood transfusions after cardiovascular surgeries. 2016
• Primary cancer prevention by green tea, and tertiary cancer prevention by the combination of green tea catechins and anticancer compounds. 2015
• Treatment and survival among 1594 patients with ATL diagnosed in the 2000s: a report from the ATL-PI project performed in Japan. 2015
• Highlights of the Twelfth Japan-Korea Joint Symposium on Cancer and Ageing Research. 2015
• Usefulness of plasma HGF level for monitoring acquired resistance to EGFR tyrosine kinase inhibitors in non-small cell lung cancer. 2015
• 2-Hydroxypropyl-β-Cyclodextrin Acts as a Novel Anticancer Agent. 2015
• Inhibition of mammalian target of rapamycin by Torin2, an ATP-competitive inhibitor, induces growth inhibition in adult T cell leukemia 2015
• Correlation between plasma DNA and tumor status in an animal model. 2014
• Synergistic enhancement of anticancer effects on numerous human cancer cell lines treated with the combination of EGCG, other green tea catechins, and anticancer compounds. 2014
• ABL tyrosine kinase inhibitor-induced pulmonary alveolar proteinosis in chronic myeloid leukemia. 2014
• Therapeutic management in cardiac lymphoma. 2014
• Liquid biopsy using circulating cell-free DNA as a powerful tool for monitoring tumor dynamics in clinical oncology 2014
• Efficacy and toxicity of mogamulizumab for relapsed/refractory adult T-cell leukemia-lymphoma: a retrospective analysis in Saga prefecture, Japan.  2014
• 2-Hydroxypropyl-β-cyclodextrin acts as a novel anticancer agent.  2014
• Monitoring of metastasis by detection of EGFR mutation, T790M, with plasma using animal model for metastasis of human lung cancer.  2014
• Usefulness of peripheral blood for monitoring of acquired resistance to EGFR tyrosine kinase inhibitors in non-small cell lung cancer.  2014
• Diffuse bone marrow uptake of FDG in a patient with aleukemic acute lymphoblastic leukemia.  2014
• A partial E Ⅲ (EFM) patient with rare genotype expressing anti-E antibody after transfusion of platelet concentrates. 2014
• Two cases of immune thrombocytopenic purpura with multiple cerebral microbleeds.  2014
• 2-Hydroxypropyl-β-cyclodextrin acts as a novel anticancer agent.  2014
• Development of lymphoproliferative diseases by hypoxia inducible factor-1alpha is associated with prolonged lymphocyte survival. 2013
• Therapeutic management in cardiac lymphoma. 2013
• Tumor promoters: from chemicals to inflammatory proteins 2013
• Establishment of a rapid and automated detection system for BRAF mutations in malignant melanoma 2013
• Development of animal model mimicking metastasis of human lung cancers using NOJ/SCID mice 2013
• Establishment of automated monitoring program for transfusional iron overload using electronic medical recording system. 2013
• Deferasirox in iron-overloaded patients with hematologic disease at Saga University Hospital 2013
• 10 cases of Mogamulizumab treatment for Adult T cell Leukemia in Saga prefecture. 2013
• Is there any environmental differences to the occurrence of CRBSI in hematological patients? 2013
• Successful reduced-intensity umbilical cord blood transplant for fulminant hemophagocytic syndrome in an adult with pre-existing rheumatoid arthritis and autoimmune hemolytic anemia. 2012
• Prognostic index for acute- and lymphoma-type adult T-cell leukemia/lymphoma 2012
• Platelets with a W127X mutation in GPIX express sufficient residual amounts of GPIbα to support adhesion to von Willebrand factor and collagen. 2012
• Co-existence of positive MET FISH status with EGFR mutations signifies poor prognosis in lung adenocarcinoma patients. 2012
• A noninvasive system for monitoring resistance to epidermal growth factor receptor tyrosine kinase inhibitors with plasma DNA. 2012
• Influences of %T>MIC achievement probability due to the difference of the MIC measurement concentration range-analysis of meropenem for Pseudomonas aerugin 2012
• The role of hypoxia inducible factors on maintenance of hematopoietic stem cells and leukemogenesis 2012
• Mechanisms of resistance to EGFR tyrosine kinase inhibitors involving HER-family ligands and receptors 2012
• Taylor made treatment using monitoring biomarkers for acquired resistance to molecular targeted therapy 2012
• DNA dependent protein kinase as a new molecular target for treatment of non-small cell lung cancer 2012
• Co-existence of positive MET FISH status with EGFR mutations signifies poor prognosis in lung adenocarcinoma 2012
• Application of MALDI-TOF MS-based strain typing for characterization of epidemiological relationships among bacterial atrains 2012
• Coexistence of invasive cryptococcosis and mature B-cell neoplasm in an HIV-negative young adult 2012
• Acute myeloid leukemia with t(3;8)(q26;q24) and monosomy 7 complicated by diabetes inspidus 2012
• Gangrenous cheilitis associated with all-trans retinoic acid therapy for acute promyelocytic leukemia. 2010
• Expression of Mina53, a novel c-Myc target gene, is a favorable prognostic marker in early stage lung cancer. 2010
• Expression of Mina53, a novel c-Myc target gene, is a favorable prognostic marker in early stage lung cancer. 2010
• Retrospective and prospective studies of hepatitis B virus reactivation in malignant lymphoma with occult HBV carrier. 2009
• Exon 19 of EGFR mutation in relation to the CA-repeat polymorphism in intron 1 2008
• Establishment of a new method, transcription-reverse transcription concerted reaction, for detection of plasma hnRNP B1 mRNA, a biomarker of lung cancer, 2008
• Significantly increased antibody response to heterogeneous nuclear ribonucleoproteins in cerebrospinal fluid of multiple sclerosis patients but not in patients with human T-lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis, 2008
• Mutation profile of EGFR gene detected by denaturing high-performance liquid chromatography in Japanese lung cancer patients, 2007/02
• Phase II study of chemotherapy and stem cell transplantation for adult acute lymphoblastic leukemia or lymphoblastic lymphoma: Japan Clinical Oncology Group study 9004. 2007
• Non-germinal cell phenotype and bcl-2 expression in primary adrenal diffuse large B-cell lymphoma. 2007
• Expression of Myc target gene mina53 in subtypes of human lymphoma. 2007
• Carcinogenesis mediated through hnRNP B1:Molecular target for early detection and treatment. 2007
• Inhibition of Double-strand DNA Break Repair by hnRNP B1 Meddiated through interactionwith DNA-dependent Protein Kinase Complex in Adult T-cell Leukemia 2007
• Inhibition of DNA repair system by hnRNP B1, an early detection marker for lung cancers, mediated through direct interaction with DNA-dependent protein kinase complex 2007
• Autoregulation of hnRNP A2/B1 gene promoter by hnRNP B1 protein, an early detection marker for lung cancer, and down regulation by DNA-PK complex in lung cancer cells. 2007
• 肺がん早期診断マーカーhnRNP B1によるhnRNP A2/B1プロモーターの自己制御 2007
• Heterogeneous nuclear ribonucleoprotein B1 expression in malignant mesothelioma 2006/11
• Clinico-pathological characteristics of p63 expression in B-cell lymphoma 2006/09
• Hsp90 inhibitors cause G2/M arrest associated with the reduction of Cdc25C and Cdc2 in lung cancer cell lines 2006/03
• Hepatitis B and C viruses infection, lifestyle and genetic polymorphisms as risk factors for hepatocellular carcinoma in Haimen, China. 2002/12
• Lung cancer prevention with (-)-epigallocatechin gallate using monitoring by heterogeneous nuclear ribonucleoprotein B1 2002/06

Books

• Technical Lecture Development and clinical use of an application for management of drug holidays in perioperative periods;　2021/06
  ANNOUNCEMENT INFO.;　Japanese Journal of Thrombosis and Hemostasis, 32, 3, 339 - 348
  AUTHOR;　○Sakiko KIMURA, Eisaburo SUEOKA, Shinya KIMURA
  

Original Articles

• HTLV-1 cell-free DNA in plasma as a potential biomarker in HTLV-1 carriers and adult T-cell leukemia-lymphoma;　2023/05
  ANNOUNCEMENT INFO.;　EJHaem, 4, 3, 733-737
  AUTHOR;　○Katsuya H, Nakamura H, Maeda A, Ishii K, Nagaie T, Sano H, Sano H, Itamura H, Okamoto S, Ando T, Watanabe T, Uchimaru K, Satou Y, Sueoka E, Kimura S
  
• Dual targeting of aberrant DNA and histone methylation synergistically suppresses tumor cell growth in ATL;　2023/04
  ANNOUNCEMENT INFO.;　Blood Adv, 7, 8, 1545-1559
  AUTHOR;　○Kurahashi Y, Watanabe T, Yamamoto Y, Ureshino H, Kamachi K, Yoshida-Sakai N, Fukuda-Kurahashi Y, Yamashita S, Hattori N, Nakamura H, Kawaguchi A, Ushijima T, Sueoka E, Kimura S
  
• Usefulness of blood biomarkers for predicting venous thromboembolism in Japanese patients with cancer;　2023/03
  ANNOUNCEMENT INFO.;　Oncol Lett, 25, 5, 180
  AUTHOR;　○Harada Y, Sato A, Nishioka A, Ogusu S, Matsumoto M, Sueoka E, Kawaguchi A, Kimura S, Sueoka-Aragane N
  
• Originals EFFICACY AND INDICATION OF CRYOPRECIPITATE PLASMA FOR PATIENTS RECEIVING CRYOPRECIPITATE IN A SINGLE INSTITUTION;　2023/02
  ANNOUNCEMENT INFO.;　Japanese Journal of Transfusion and Cell Therapy, 69, 1, 1-7
  AUTHOR;　○Yoshinori Tanigawa, Akira Nakagawachi, Kimihide Nakamura, Tomoko Yamashita, Mayumi Nakao, Naotomo Yamada, Marie Yamada, Hideaki Nakamura, Hidekazu Itamura, Eizaburou Sueoka, Hidekazu Setoguchi, Yoshiro Sakaguchi
  
• Management system of home transfusion in Japan: A nationwide survey in 2019;　2023/01
  ANNOUNCEMENT INFO.;　Vox Sang, 118, 1, 59-67
  AUTHOR;　*Tanaka A, Fujita H, Ohashi K, Tsujikawa A, Uchiyama K, Ito T, Kawashima K, Kodama R, Mine T, Okuda M, Endoh T, Fukuyoshi Y, Kitazawa J, Sueoka E, Nagai K, Ishida A, Matsuzaki K, Kato Y, Takanashi K, Takahashi K
  
• Anti-cancer effect of afatinib, dual inhibitor of HER2 and EGFR, on novel mutation HER2 E401G in models of patient-derived cancer;　2023/01
  ANNOUNCEMENT INFO.;　BMC Cancer, 23, 1, 77
  AUTHOR;　○Harada Y, Sato A, Nakamura H, Kai K, Kitamura S, Nakamura T, Kurihara Y, Ikeda S, Sueoka E, Kimura S, Sueoka-Aragane N
  
• Cytological Comparison between Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma by Image Analysis Software Using Touch Smear Samples of Surgically Resected Specimens ;　2022/05
  ANNOUNCEMENT INFO.;　Cancers (Basel), 14, 9, 2301
  AUTHOR;　Sho Kitamura, Keita Kai, Mitsuo Nakamura, Tomokazu Tanaka, Takao Ide, Hirokazu Noshiro, Eisaburo Sueoka, Shinich Aishima
  
• Clinical utility of comprehensive genomic profiling in Japan: Result of PROFILE-F study ;　2022/03
  ANNOUNCEMENT INFO.;　PLoS One, 17, 3, e0266112
  AUTHOR;　*Aoyagi Y, Kano Y, Tohyama K, Matsudera S, Kumaki Y, Takahashi K, Mitsumura T, Harada Y, Sato A, Nakamura H, Sueoka E, Aragane N, Kimura K, Onishi I, Takemoto A, Akahoshi K, Ono H, Ishikawa T, Tokunaga M, Nakagawa T, Oshima N, Nakamura R, Takagi M, Asakage T, Uetake H, Tanabe M, Miyake S, Kinugasa Y, Ikeda S
  
• Integrated approach to functional analysis of an ERBB2 variant of unknown significance detected by a cancer gene panel test ;　2022/02
  ANNOUNCEMENT INFO.;　Cell Oncol (Dordr), 45, 1, 121-134
  AUTHOR;　○Harada Y, Sato A, Araki M, Matsumoto S, Isaka Y, Sagae Y, Abe T, Aoyagi Y, Sueoka E, Okuno Y, Kimura S, Sueoka-Aragane N
  
• HTLV-1 infection promotes excessive T cell activation and transformation into adult T cell leukemia/lymphoma;　2021/12
  ANNOUNCEMENT INFO.;　J Clin Invest, 131, 24, e150472
  AUTHOR;　*Benjy Jy Tan, Kenji Sugata, Omnia Reda, Misaki Matsuo, Kyosuke Uchiyama, Paola Miyazato, Vincent Hahaut, Makoto Yamagishi, Kaoru Uchimaru, Yutaka Suzuki, Takamasa Ueno, Hitoshi Suzushima, Hiroo Katsuya, Masahito Tokunaga, Yoshikazu Uchiyama, Hideaki Nakamura, Eisaburo Sueoka, Atae Utsunomiya, Masahiro Ono, Yorifumi Satou
  
• Correlation of Strain Classification with IR Biotyper and Molecular Epidemiological Method of Pseudomonas aeruginosa;　2021/12
  ANNOUNCEMENT INFO.;　Rinsho Biseibutshu Jinsoku Shindan Kenkyukai Shi, 31, 1, 29-40
  AUTHOR;　Oho M, Nagasawa Z, Funashima Y, Ueda O, Watamabe S, Cui L, Miyamoto H, Sueoka E
  
• Effect of skin-capsular distance on controlled attenuation parameter for diagnosing liver steatosis in patients with nonalcoholic fatty liver disease ;　2021/08
  ANNOUNCEMENT INFO.;　Sci Rep, 11, 1, 15641
  AUTHOR;　○Syunichiro Kimura, Kenichi Tanaka, Satoshi Oeda, Kaori Inoue, Chika Inadomi, Yoshihito Kubotsu, Wataru Yoshioka, Michiaki Okada, Hiroshi Isoda, Takuya Kuwashiro, Takumi Akiyama, Aya Kurashige, Ayaka Oshima, Mayumi Oshima, Yasue Matsumoto, Atsushi Kawaguchi, Keizo Anzai, Eisaburo Sueoka, Shinichi Aishima, Hirokazu Takahashi
  
• ALDH2 polymorphism rs671 is a predictor of PD-1/PD-L1 inhibitor efficacy against thoracic malignancies ;　2021/05
  ANNOUNCEMENT INFO.;　BMC Cancer, 21, 1, 584
  AUTHOR;　○Akiko Matsumoto, Chiho Nakashima, Shinya Kimura, Eizaburo Sueoka, Naoko Aragane
  
• Role of TNF-α-Inducing Protein Secreted by Helicobacter pylori as a Tumor Promoter in Gastric Cancer and Emerging Preventive Strategies ;　2021/03
  ANNOUNCEMENT INFO.;　Toxins (Basel), 13, 3, 181
  AUTHOR;　*Masami Suganuma, Tatsuro Watanabe, Eisaburo Sueoka, In Kyoung Lim, Hirota Fujiki
  
• Clinical significance of soluble CADM1 as a novel marker for adult T-cell leukemia/lymphoma;　2021/02
  ANNOUNCEMENT INFO.;　Haematologica, 106, 2, 532-542
  AUTHOR;　*Shingo Nakahata, Chilmi Syahrul, Ayako Nakatake, Kuniyo Sakamoto, Maki Yoshihama, Ichiro Nishikata, Yoshinori Ukai, Tadashi Matsuura, Takuro Kameda, Kotaro Shide, Yoko Kubuki, Tomonori Hidaka, Akira Kitanaka, Akihiko Ito, Shigeki Takemoto, Nobuaki Nakano, Masumichi Saito, Masako Iwanaga, Yasuko Sagara, Kosuke Mochida, Masahiro Amano, Kouichi Maeda, Eisaburo Sueoka, Akihiko Okayama, Atae Utsunomiya, Kazuya Shimoda, Toshiki Watanabe, Kazuhiro Morishita
  
• Rapid detection method of carbapenemase-producing Enterobacteriaceae by MALDI-TOF MS with imipenem/cilastatin (KB) disc and zinc sulfate solution;　2021/02
  ANNOUNCEMENT INFO.;　J Infect Chemother, 27, 2, 205-210
  AUTHOR;　Megumi Oho, Yumiko Funashima, Zenzo Nagasawa, Hiroshi Miyamoto, Eisaburo Sueoka
  
• Targeting aberrant DNA hypermethylation as a driver of ATL leukemogenesis by using the new oral demethylating agent OR-2100;　2020/08
  ANNOUNCEMENT INFO.;　Blood, 136, 7, 871-884
  AUTHOR;　○Tatsuro Watanabe, Satoshi Yamashita, Hiroshi Ureshino, Kazuharu Kamachi, Yuki Kurahashi, Yuki Fukuda-Kurahashi, Nao Yoshida, Naoko Hattori, Hideaki Nakamura, Akemi Sato, Atsushi Kawaguchi, Naoko Sueoka-Aragane, Kensuke Kojima, Seiji Okada, Toshikazu Ushijima, Shinya Kimura, Eisaburo Sueoka
  
• Development of Continuous Validation Model on Standard Codes Mapping for Multi-Institutional Collaborative Data-Driven Medical Study;　2020/08
  ANNOUNCEMENT INFO.;　EJBI, 16, 3, 10-19
  AUTHOR;　*Park J, Yamashita T, Takada A, Hotta T, Nojiri C, Izukura R, Fujimura Y, Kimura M, Nakayama M, Ohe K, Orii T, Sueoka E, Suzuki T, Yokoi H, Kang D, Nakashima N
  
• Origin of circulating free DNA in patients with lung cancer;　2020/07
  ANNOUNCEMENT INFO.;　PLoS One, 15, 7, e0235611
  AUTHOR;　○Tomonori Abe, Chiho Nakashima, Akemi Sato, Yohei Harada, Eisaburo Sueoka, Shinya Kimura, Atsushi Kawaguchi, Naoko Sueoka-Aragane
  
• Diagnostic accuracy of FibroScan-AST score to identify non-alcoholic steatohepatitis with significant activity and fibrosis in Japanese patients with non-alcoholic fatty liver disease: Comparison between M and XL probes;　2020/07
  ANNOUNCEMENT INFO.;　Hepatol Res, 50, 7, 831-839
  AUTHOR;　○Satoshi Oeda, Hirokazu Takahashi, Kento Imajo, Yuya Seko, Takashi Kobayashi, Yuji Ogawa, Michihisa Moriguchi, Masato Yoneda, Keizo Anzai, Hiroyuki Irie, Eisaburo Sueoka, Shinichi Aishima, Masayoshi Kage, Yoshito Itoh, Yuichiro Eguchi, Atsushi Nakajima
  
• Development of an application for management of drug holidays in perioperative periods;　2020/05
  ANNOUNCEMENT INFO.;　Medicine (Baltimore), 99, 19, e20142
  AUTHOR;　○Sakiko Kimura, Akiko Emoto, Mariko Yoshimura, Kota Arimizu, Tomoko Kamura, Rintaro Sogawa, Kikumi Mizuta, Yasuhiro Tagomori, Masahiro Natsuaki, Masataka Kajiwara, Nanae Tsuruoka, Yusuke Yakushiji, Yoshinori Tanigawa, Chihiro Takamatsu, Atsushi Danjo, Keiji Kamohara, Naomi Hirakawa, Yoshiro Sakaguchi, Mitsuru Noguchi, Hirokazu Noshiro, Atsushi Kawaguchi, Eisaburo Sueoka, Yutaka Narisawa, Shinya Kimura
  
• Development and Evaluation of Screening Culture Medium for Detection of Drug-Resistant Gram Negative Rods Containing Stealth Type CPE;　2020/03
  ANNOUNCEMENT INFO.;　Rinsho Biseibutshu Jinsoku Shindan Kenkyukai Shi, 29, 2, 75-86
  AUTHOR;　Chinatsu Komatsu, Megumi Oho, Kouji Kusaba, Seiji Kawasaki, Nohara Tsukamoto, Yuya Hirata, Yoshihiro Nagasawa, Yumiko Funashima, Zenzo Nagasawa, Eizaburo Sueoka
  
• Clinical impact of the CONUT score in patients with multiple myeloma;　2020/01
  ANNOUNCEMENT INFO.;　Ann Hematol, 99, 1, 113-119
  AUTHOR;　○Sho Okamoto, Hiroshi Ureshino, Keisuke Kidoguchi, Kana Kusaba, Haruna Kizuka-Sano, Haruhiko Sano, Atsujiro Nishioka, Kyosuke Yamaguchi, Kazuharu Kamachi, Hidekazu Itamura, Mariko Yoshimura, Masako Yokoo, Takero Shindo, Yasushi Kubota, Toshihiko Ando, Kensuke Kojima, Atsushi Kawaguchi, Eisaburo Sueoka, Shinya Kimura
  
• POSITIVE RATE OF BLOOD PRODUCTS IN THE IRREGULAR ANTIBODY SCREENING TEST AND THE SIGNIFICANCE OF MINOR CROSSMATCHING IN THE CROSSMATCH TEST;　2019/12
  ANNOUNCEMENT INFO.;　Japanese Journal of Transfusion and Cell Therapy, 65, 6, 865-869
  AUTHOR;　Marie Yamada, Naotomo Yamada, Mami Nakao, Yasushi Kubota, Shinya Kimura, Eisaburo Sueoka
  
• Establishment of the MID‐NET® medical information database network as a reliable and valuable database for drug safety assessments in Japan;　2019/10
  ANNOUNCEMENT INFO.;　Pharmacoepidemiol Drug Saf. , 28, 10, 1395-1404
  AUTHOR;　*Yamaguchi M, Inomata S, Harada S, Matsuzaki Y, Kawaguchi M, Ujibe M, Kishiba M, Fujimura Y, Kimura M, Murata K, Nakashima N, Nakayama M, Ohe K, Orii T, Sueoka E, Suzuki T, Yokoi H, Takahashi F, Uyama Y.　
  
• Primary Chest Wall MYC/BCL6 Double-hit Lymphoma with t (3;7) (q27;p12) and t (8;14) (q24;q32) Translocations.;　2019/07
  ANNOUNCEMENT INFO.;　Intern Med. , 58, 14, 2073-2077
  AUTHOR;　○Kamachi K, Kubota Y, Nagaie T, Yamaguchi K, Ogusu S, Kidoguchi K, Kusaba K, Kizuka-Sano H, Nishioka A, Yoshimura M, Yokoo M, Ando T, Kai K, Kojima K, Ohshima K, Sueoka E, Kimura S.
  
• Meeting report of the 14th Japan-Korea joint symposium on cancer and aging research: current status of translational research and approaches to precision medicine. ;　2019/05
  ANNOUNCEMENT INFO.;　J Cancer Res Clin Oncol. , 145, 5, 1263-1271
  AUTHOR;　Sueoka E, Watanabe T, Mashima T, Shirakami Y, Komori A, Matsuo K, Yoshikawa HY, Cho KA, Park TJ, Seimiya H, Kim EG, Suganuma M, Chung J.
  
• The utilization and challenges of Japan's MID‐NET® medical information database network in postmarketing drug safety assessments: A summary of pilot pharmacoepidemiological studies;　2019/05
  ANNOUNCEMENT INFO.;　Pharmacoepidemiol Drug Saf. , 28, 5, 601-608
  AUTHOR;　*Yamada K, Itoh M, Fujimura Y, Kimura M, Murata K, Nakashima N, Nakayama M, Ohe K, Orii T, Sueoka E, Suzuki T, Yokoi H, Ishiguro C, Uyama Y
  
• Clinical impact of the CONUT score and mogamulizumab in adult T cell leukemia/lymphoma;　2019/02
  ANNOUNCEMENT INFO.;　Ann Hematol, 98, 2, 465-471
  AUTHOR;　○Hiroshi Ureshino, Kana Kusaba, Keisuke Kidoguchi, Haruhiko Sano, Atsujiro Nishioka, Hidekazu Itamura, Mariko Yoshimura, Masako Yokoo, Takero Shindo, Yasushi Kubota, Toshihiko Ando, Kensuke Kojima, Eisaburo Sueoka, Shinya Kimura
  
• Acute myeloid leukemia with t (19;21)(q13;q22) and marked eosinophilia;　2019/01
  ANNOUNCEMENT INFO.;　Ann Hematol, 98, 1, 221-222
  AUTHOR;　○Yasushi Kubota, Kazuharu Kamachi, Kazuo Wakayama, Hiroaki Kitamura, Mari Yoshihara, Takashi Hisatomi, Noriyasu Fukushima, Tatsuo Ichinohe, Eisaburo Sueoka, Shinya Kimura
  
• Incidence of aspiration pneumonia during hospitalization in Japanese hospitalized cases did not increase whereas concern factors were exacerbated in a time-dependent manner: analysis of Diagnosis Procedure Combination (DPC) data.;　2018
  ANNOUNCEMENT INFO.;　J Clin Biochem Nutr. , 63, 1, 66-69
  AUTHOR;　○Nonaka S, Fujii S, Hara M, Morita S, Sueoka E, Node K, Fujimoto K.
  
• Differentiated embryo chondrocyte plays a crucial role in DNA damage response via transcriptional regulation under hypoxic conditions.;　2018
  ANNOUNCEMENT INFO.;　PLoS One. , 13, 2, e0192136
  AUTHOR;　Nakamura H, Bono H, Hiyama K, Kawamoto T, Kato Y, Nakanishi T, Nishiyama M, Hiyama E, Hirohashi N, Sueoka E, Poellinger L, Tanimoto K
  
• Automated DNA extraction using cellulose magnetic beads can improve EGFR point mutation detection with liquid biopsy by efficiently recovering short and long DNA fragments.;　2018
  ANNOUNCEMENT INFO.;　Oncotarget. , 9, 38, 25181-2519
  AUTHOR;　○Nakashima C, Sato A, Abe T, Kato J, Hirai M, Nakamura T, Komiya K, Sueoka E, Kimura S, Sueoka-Aragane N.
  
• Investigation of appropriate pre-analytical procedure for circulating free DNA from liquid biopsy.;　2018
  ANNOUNCEMENT INFO.;　Oncotarget. , 9, 61, 31904-31914
  AUTHOR;　Sato A, Nakashima C, Abe T, Kato J, Hirai M, Nakamura T, Komiya K, Kimura S, Sueoka E, Sueoka-Aragane N.
  
• Identification of the BRAF V600E mutation in Japanese patients with hairy cell leukemia and related diseases using a quenching probe method.;　2018
  ANNOUNCEMENT INFO.;　Int J Hematol. , 108, 4, 416-422
  AUTHOR;　＊Itamura H, Ide M, Sato A, Sueoka-Aragane N, Sueoka E, Nishida A, Masunari T, Aoki S, Takizawa J, Suzumiya J, Kimura S.
  
• Synchronous mantle cell lymphoma and lung adenocarcinoma presenting in a pleural effusion: A rare tumour combination and a potential pitfall of cytodiagnosis.;　2018
  ANNOUNCEMENT INFO.;　Cytopathology., 29, 4, 400-402
  AUTHOR;　〇Kai K, Ryu Y, Kamochi K, Nishioka A, Kubota Y, Nakamura M, Kimura S, Sueoka E, Aishima S
  
• Community-acquired Disseminated Exophiala dermatitidis Mycosis with Necrotizing Fasciitis in Chronic Graft-versus-host Disease. ;　2018
  ANNOUNCEMENT INFO.;　Intern Med.
  AUTHOR;　〇Sato E, Togawa A, Masaki M, Shirahashi A, Kumagawa M, Kawano Y, Ishikura H, Yamashiro Y, Takagi S, To H, Kobata K, Takeshita M, Kusaba K, Sueoka E, Tamura K, Takamatsu Y, Takata T.
  
• Functional analysis of Discoidin domain receptor 2 mutation and expression in squamous cell lung cancer.;　2017
  ANNOUNCEMENT INFO.;　Lung Cancer. , 110, 35-41
  AUTHOR;　〇Kobayashi-Watanabe N, Sato A, Watanabe T, Abe T, Nakashima C, Sueoka E, Kimura S, Sueoka-Aragane N.
  
• Plasma T790M and HGF as potential predictive markers for EGFR-TKI re-challenge.;　2017
  ANNOUNCEMENT INFO.;　Oncol Lett. , 13, 6, 4939-4946
  AUTHOR;　○Nakamura T, Watanabe N, Sato A, Komiya K, Umeguchi H, Hosomi T, Hirai M, Sueoka E, Kimura S, Sueoka-Aragane N.
  
• Mutation profile of B-raf gene analyzed by fully automated system and clinical features in Japanese melanoma patients;　2017
  ANNOUNCEMENT INFO.;　Pathol Oncol Res. , 23, 1, 181-188
  AUTHOR;　＊Ide M, Koba K, Sueoka-Aragane N, Sato A, Nagano Y, Inoue T, Misago N, Narisawa Y, Kimura S, Sueoka E
  
• Torin2 potentiates anti-cancer effects for adult T-cell leukemia/lymphoma by inhibiting mammalian target of rapamycin.;　2016
  ANNOUNCEMENT INFO.;　Anticancer Res., 36, 1, 95-102
  AUTHOR;　Watanabe T, Sato A, Kobayashi-Watanabe N, Sueoka-Aragane N, Kimura S, Sueoka E
  
• Reversible Liver Steatosis Induced by Chemotherapy of Mixed-phenotype Acute Leukemia.;　2016
  ANNOUNCEMENT INFO.;　Intern Med., 55, 8, 1025-6
  AUTHOR;　○Nishioka A, Kubota Y, Sueoka E, Kimura S.
  
• Acute myeloid leukemia with t(3;8)(q26;q24) complicated by diabetes insipidus. ;　2016
  ANNOUNCEMENT INFO.;　Ann Hematol., 95, 4, 653-5
  AUTHOR;　○Kubota Y, Ichinohe T, Yoshimura M, Itamura H, Hisatomi T, Fukushima N, Sueoka E, Kimura S.
  
• Erratum to "Expression of Mina53, a novel c-Myc target gene, is a favorable prognostic marker in early stage lung cancer" [Lung Cancer 69/2 (2010) 232-238].;　2016
  ANNOUNCEMENT INFO.;　Lung Cancer., 101, 148
  AUTHOR;　○Komiya K, Sueoka-Aragane N, Sato A, Hisatomi T, Sakuragi T, Mitsuoka M, Sato T, Hayashi S, Izumi H, Tsuneoka M, Sueoka E.
  
• Primary cancer prevention by green tea, and tertiary cancer prevention by the combination of green tea catechins and anticancer compounds.;　2015
  ANNOUNCEMENT INFO.;　J Cancer Prev., 20, 1, 1-4
  AUTHOR;　Fujiki H, Sueoka E, Watanabe T, Suganuma M.
  
• Treatment and survival among 1594 patients with ATL diagnosed in the 2000s: a report from the ATL-PI project performed in Japan.;　2015
  ANNOUNCEMENT INFO.;　Blood., 126, 24, 2570-7
  AUTHOR;　＊Katsuya H, Ishitsuka K, Utsunomiya A, Hanada S, Eto T, Moriuchi Y, Saburi Y, Miyahara M, Sueoka E, Uike N, Yoshida S, Yamashita K, Tsukasaki K, Suzushima H, Ohno Y, Matsuoka H, Jo T, Amano M, Hino R, Shimokawa M, Kawai K, Suzumiya J, Tamura K.　
  
• Highlights of the Twelfth Japan-Korea Joint Symposium on Cancer and Ageing Research.;　2015
  ANNOUNCEMENT INFO.;　J Cancer Res Clin Oncol., 141, 11, 1953-61
  AUTHOR;　＊Suganuma M, Park TJ, Sueoka E, Iida K, Tanaka Y.
  
• Usefulness of plasma HGF level for monitoring acquired resistance to EGFR tyrosine kinase inhibitors in non-small cell lung cancer.;　2015
  ANNOUNCEMENT INFO.;　Oncol Rep., 33, 1, 391-6
  AUTHOR;　＊Umeguchi H, Sueoka-Aragane N, Kobayashi N, Nakamura T, Sato A, Takeda Y, Hayashi S, Sueoka E, Kimura S.
  
• 2-Hydroxypropyl-β-Cyclodextrin Acts as a Novel Anticancer Agent.;　2015
  ANNOUNCEMENT INFO.;　PLoS One., 10, 11, e0141946
  AUTHOR;　＊Yokoo M, Kubota Y, Motoyama K, Higashi T, Taniyoshi M, Tokumaru H,Nishiyama R, Tabe Y, Mochinaga S, Sato A, Sueoka-Aragane N, Sueoka E, Arima H, Irie T, Kimura S.
  
• Correlation between plasma DNA and tumor status in an animal model.;　2014
  ANNOUNCEMENT INFO.;　PLoS One. , 9, 12, e111881
  AUTHOR;　○Sueoka-Aragane N, Sato A, Kobayashi N, Ide M, Yokoo M, Nagano Y, Sueoka E, Okada S, Kimura S.
  
• Synergistic enhancement of anticancer effects on numerous human cancer cell lines treated with the combination of EGCG, other green tea catechins, and anticancer compounds.;　2014
  ANNOUNCEMENT INFO.;　J Cancer Res Clin Oncol.
  AUTHOR;　○Fujiki H, Sueoka E, Watanabe T, Suganuma M.
  
• ABL tyrosine kinase inhibitor-induced pulmonary alveolar proteinosis in chronic myeloid leukemia.;　2014
  ANNOUNCEMENT INFO.;　Int J Hematol. , 100, 6, 611-4
  AUTHOR;　○Yoshimura M, Kojima K, Tomimasu R, Fukushima N, Hayashi S, Sueoka E, Kimura S.
  
• Therapeutic management in cardiac lymphoma.;　2014
  ANNOUNCEMENT INFO.;　Leuk Lymphoma. , 55, 5, 1215-7
  AUTHOR;　○Yoshihara M, Itamura H, Fukushima N, Itoh M, Furukawa K, Nagatomo D, Kamachi K, Kitamura H, Shindo T, Kubota Y, Sueoka E, Morita S, Ichinohe T, Kimura S.
  
• Development of lymphoproliferative diseases by hypoxia inducible factor-1alpha is associated with prolonged lymphocyte survival.;　2013
  ANNOUNCEMENT INFO.;　PLoS One, doi: 10.1371/journal.pone.0057833., 8, 4, e57833
  AUTHOR;　Sueoka E, Sueoka-Aragane N, Sato A, Ide M, Nakamura H, Sotomaru Y, Taya C, Yonekawa H, Kitagawa T, Kubota Y, Kimura S, Nakachi K, Tanimoto K.
  
• Therapeutic management in cardiac lymphoma.;　2013
  ANNOUNCEMENT INFO.;　Leuk Lymphoma, doi: 10.3109/10428194.2013.828355., 55, 5, 1215-1217
  AUTHOR;　Yoshihara M, Itamura H, Fukushima N, Itoh M, Furukawa K, Nagatomo D, Kamachi K, Kitamura H, Shindo T, Kubota Y, Sueoka E, Morita S, Ichinohe T, Kimura S.
  
• Tumor promoters: from chemicals to inflammatory proteins;　2013
  ANNOUNCEMENT INFO.;　J Cancer Res Clin Oncol, doi: 10.1007/s00432-013-1455-8., 139, 10, 1603-1614
  AUTHOR;　*Fujiki H ,Sueoka E, Suganuma M
  
• Successful reduced-intensity umbilical cord blood transplant for fulminant hemophagocytic syndrome in an adult with pre-existing rheumatoid arthritis and autoimmune hemolytic anemia.;　2012
  ANNOUNCEMENT INFO.;　Leuk Lymphoma., 53, 11, 2307-2309
  AUTHOR;　○Itamura H, Fukushima N, Kondo S, Urata C, Tanaka-Yoshimura M, Yokoo M, Ide M, Hisatomi T, Kubota Y, Sueoka E, Ichinohe T, Kimura S.
  
• Prognostic index for acute- and lymphoma-type adult T-cell leukemia/lymphoma;　2012
  ANNOUNCEMENT INFO.;　J Clin Oncol., 30, 14, 1635-1640
  AUTHOR;　○Katsuya H, Yamanaka T, Ishitsuka K, Utsunomiya A, Sasaki H, Hanada S, Eto T, Moriuchi Y, Saburi Y, Miyahara M, Sueoka E, Uike N, Yoshida S, Yamashita K, Tsukasaki K, Suzushima H, Ohno Y, Matsuoka H, Jo T, Suzumiya J, Tamura K
  
• Platelets with a W127X mutation in GPIX express sufficient residual amounts of GPIbα to support adhesion to von Willebrand factor and collagen.;　2012
  ANNOUNCEMENT INFO.;　Int J Hematol., 96, 6, 733-742
  AUTHOR;　○Takata Y, Kanaji T, Moroi M, Seki R, Sano M, Nakazato S, Sueoka E, Imamura Y, Okamura T
  
• Co-existence of positive MET FISH status with EGFR mutations signifies poor prognosis in lung adenocarcinoma patients.;　2012
  ANNOUNCEMENT INFO.;　Lung Cancer., 75, 1, 89-94
  AUTHOR;　○Tanaka A, Sueoka-Aragane N, Nakamura T, Takeda Y, Mitsuoka M, Yamasaki F, Hayashi S, Sueoka E, Kimura S
  
• A noninvasive system for monitoring resistance to epidermal growth factor receptor tyrosine kinase inhibitors with plasma DNA.;　2012
  ANNOUNCEMENT INFO.;　J Thorac Oncol., 6, 10, 1639-1648
  AUTHOR;　○Nakamura T, Sueoka-Aragane N, Iwanaga K, Sato A, Komiya K, Abe T, Ureshino N, Hayashi S, Hosomi T, Hirai M, Sueoka E, Kimura S
  
• Influences of %T>MIC achievement probability due to the difference of the MIC measurement concentration range-analysis of meropenem for Pseudomonas aerugin;　2012
  ANNOUNCEMENT INFO.;　Rinsho Biseibutshu Jinsoku Shindan Kenkyukai Shi (Japanese), 22, 1-2, 11-22
  AUTHOR;　Nagasawa Z, Nakashima Y, Fukutomi Y, Uki N, Kusaba K, Nagumo F, Ohta S, Sueoka E, Miyamoto H.
  
• Gangrenous cheilitis associated with all-trans retinoic acid therapy for acute promyelocytic leukemia.;　2010
  ANNOUNCEMENT INFO.;　Int J Hematol, 91, 132-135
  AUTHOR;　Tanaka M, Fukushima N, Itamura H, Urata C, Yokoo M, Ide M, Hisatomi T, Tomimasu R, Sueoka E, Kimura S.
  
• Expression of Mina53, a novel c-Myc target gene, is a favorable prognostic marker in early stage lung cancer.;　2010
  ANNOUNCEMENT INFO.;　, 69, 232-238
  AUTHOR;　Komiya K, Sueoka-Aragane N, Sato A, Hisatomi T, Sakuragi T, Mitsuoka M, Sato T, Hayashi S, Izumi H, Tsuneoka M, Sueoka E
  
• Expression of Mina53, a novel c-Myc target gene, is a favorable prognostic marker in early stage lung cancer.;　2010
  ANNOUNCEMENT INFO.;　Lung Cancer, 69, 232-238
  AUTHOR;　Komiya K, Sueoka-Aragane N, Sato A, Hisatomi T, Sakuragi T, Mitsuoka M, Sato T, Hayashi S, Izumi H, Tsuneoka M, Sueoka E.
  
• Retrospective and prospective studies of hepatitis B virus reactivation in malignant lymphoma with occult HBV carrier.;　2009
  ANNOUNCEMENT INFO.;　Ann Oncol, . 20, 2013-2017
  AUTHOR;　Fukushima N, Mizuta T, Tanaka M, Yokoo M, Ide M, Hisatomi T, Kuwahara N, Tomimasu R, Tsuneyoshi N, Funai N, Sueoka E.
  
• Exon 19 of EGFR mutation in relation to the CA-repeat polymorphism in intron 1;　2008
  ANNOUNCEMENT INFO.;　Cancer Sci, 99, 1180-1187
  AUTHOR;　Sueoka-Aragane N, Imai K, Komiya K, Sato A, Tomimasu R, Hisatomi T, Sakuragi T, Mitsuoka M, Hayashi S, Nakachi K, Sueoka E.
  
• Establishment of a new method, transcription-reverse transcription concerted reaction, for detection of plasma hnRNP B1 mRNA, a biomarker of lung cancer,;　2008
  ANNOUNCEMENT INFO.;　J Cancer Res Clin Oncol, 134, 1191-1197
  AUTHOR;　Sato A, Sueoka-Aragane N, Saitoh J, Komiya K, Hisatomi T, Tomimasu R, Hayashi S, Sueoka E
  
• Significantly increased antibody response to heterogeneous nuclear ribonucleoproteins in cerebrospinal fluid of multiple sclerosis patients but not in patients with human T-lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis,;　2008
  ANNOUNCEMENT INFO.;　J NeuroVirol, 14, 130-135
  AUTHOR;　Yukitake M, Sueoka E, Sato A, Aragane-Sueoka N, Ohashi H, Saito M, Izumo S, Osame M, Kuroda Y
  
• Mutation profile of EGFR gene detected by denaturing high-performance liquid chromatography in Japanese lung cancer patients,;　2007/02
  ANNOUNCEMENT INFO.;　J. Cancer Res. Clin. Oncol., 133, 2, 93-102
  AUTHOR;　Sueoka N, Sato A, Eguchi H, Komiya K, Sakuragi T, Mitsuoka M, Satoh T, Hayashi S, Nakachi K, Sueoka E.
  
• Expression and production of aberrant PAX5 with deletion of exon 8 in B-lineage acute lymphoblastic leukaemia of children;　2007/01
  ANNOUNCEMENT INFO.;　Br J Haematol, 136, 2, 297-300
  AUTHOR;　Sadakane Y, Zaitsu M, Nishi M, Sugita K, Mizutani S, Matsuzaki A, Sueoka E, Hamasaki Y, Ishii E.
  
• Phase II study of chemotherapy and stem cell transplantation for adult acute lymphoblastic leukemia or lymphoblastic lymphoma: Japan Clinical Oncology Group study 9004.;　2007
  ANNOUNCEMENT INFO.;　Cancer Sci., 98, 9, 1350-1357
  AUTHOR;　K Tobinai, K Takeyama, F Arima, T Kobayashi, S Hanada, M Kasai, S Ogura, E Sueoka, K Mukai, K Tajima, H Fukuda, S Shirakawa, T Hotta, S Masanori
  
• Non-germinal cell phenotype and bcl-2 expression in primary adrenal diffuse large B-cell lymphoma.;　2007
  ANNOUNCEMENT INFO.;　Leukemia Lymphoma, 48, 11, 2244-2246
  AUTHOR;　M Ide, N Fukushima, T Hisatomi, N Tsuneyoshi, M Tanaka, M Yokoo, R Tomimasu, N Funai, E Sueoka
  
• Expression of Myc target gene mina53 in subtypes of human lymphoma.;　2007
  ANNOUNCEMENT INFO.;　Oncology Rep, 18, 4, 841-848
  AUTHOR;　K Teye, N Arima, Y Nakamura, K Sakamoto, E Sueoka, H Kimura, M Tsuneoka:
  
• Heterogeneous nuclear ribonucleoprotein B1 expression in malignant mesothelioma;　2006/11
  ANNOUNCEMENT INFO.;　, 97, 11, 1175-1181
  AUTHOR;　Hiraki A, Murakami T, Aoe K, Sueoka E, Sueoka N, Taguchi K, Kamei T, Sugi K, Ueoka H, Kishimoto T.
  
• Clinico-pathological characteristics of p63 expression in B-cell lymphoma;　2006/09
  ANNOUNCEMENT INFO.;　Cancer Sci., 97, 11, 1175-1181
  AUTHOR;　Fukushima N, Satoh T, Sueoka N, Sato A, Ide M, Hisatomi T, Kuwahara N, Tomimasu R, Tsuneyoshi N, Funai N, Sano M, Tokunaga O, Sueoka E.
  
• Hsp90 inhibitors cause G2/M arrest associated with the reduction of Cdc25C and Cdc2 in lung cancer cell lines;　2006/03
  ANNOUNCEMENT INFO.;　J Cancer Res Clin Oncol., 132, 3, 150-158
  AUTHOR;　Senju M, Sueoka N, Sato A, Iwanaga K, Sakao Y, Tomimitsu S, Tominaga M, Irie K, Hayashi S, Sueoka E.
  
• Heterogeneous nuclear ribonucleoprotein B1 protein impairs DNA repair mediated through the inhibition of DNA-dependent protein kinase activity;　2005
  ANNOUNCEMENT INFO.;　BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 333, 3, 888-895
  AUTHOR;　Iwanaga, K / Sueoka, N / Sato, A / Hayashi, S / Sueoka, E
  
• Reply for Letter to Editor;　2005
  ANNOUNCEMENT INFO.;　Ann Neurol, 57, 931-932
  AUTHOR;　Sueoka E, Sueoka N, Sato A, Kuroda Y.
  
• Detection of plasma hnRNP B1 mRNA, a new cancer biomarker, in lung cancer patients by quantitative real-time polymerase chain reaction;　2005
  ANNOUNCEMENT INFO.;　LUNG CANCER, 48, 1, 77-83
  AUTHOR;　Sueoka, E / Sueoka, N / Iwanaga, K / Sato, A / Suga, K / Hayashi, S. i / Nagasawa, K / Nakachi, K
  
• Disseminated Ochroconis gallopavum Infection in a Chronic Lymphocytic Leukemia: A Case Report and Review of the Literature on Hematological Malignancies;　2005
  ANNOUNCEMENT INFO.;　INTERNAL MEDICINE, 44, 8, 879-882
  AUTHOR;　Fukushima, N / Mannen, K / Okamoto, S / Shinogi, T / Nishimoto, K / Sueoka, E
  
• Detection of plasma hnRNP B1 mRNA, a new cancer biomarker, in lung cancer patients by quantitative real-time polymerase chain reaction.;　2004
  ANNOUNCEMENT INFO.;　Lung Cancer, 48, 77-83
  AUTHOR;　Sueoka E,Sueoka N,Iwanaga K,Sato A,Suga K,Hayashi S,Nagasawa K,Nakachi K
  
• Presence of autoantibody against heterogeneous nuclear ribonucleoprotein B1 in cerebrospinal fluid of patients with relapsing-remitting multiple sderosis.;　2004
  ANNOUNCEMENT INFO.;　Ann Neurol, 56, 778-786
  AUTHOR;　Sueoka E,Yukitake M,Iwanaga K,Sueoka N,Aihara T and Kuroda Y
  
• Alteration of expression or phosphorylation status of tob, a novel tumor suppressor gene product, is an early event in lung cancer.;　2003
  ANNOUNCEMENT INFO.;　Cancer Lett., 202, 71-79
  AUTHOR;　Iwanaga K,Sueoka N,Sato A,Sakuragi T,Sakao Y,Tominaga M,Suzuki T,Yoshida Y,K-Tsuzuku J,Yamamoto T,Hayashi S,Nagasawa K, and Sueoka E.
  
• Detection and discrimination of preneoplastic and early stages of lung adenocarcinoma using hnRNP B1 combined with the cell cycle-related markers p16, cyclin D1, and Ki-67;　2003
  ANNOUNCEMENT INFO.;　LUNG CANCER, 40, 1, 45-53
  AUTHOR;　Tominaga, M / Sueoka, N / Irie, K / Iwanaga, K / Tokunaga, O / Hayashi, S. i / Nakachi, K / Sueoka, E
  
• hnRNP B1 protein may be a possible prognostic factor in squamous cell carcinoma of the lung.;　2003
  ANNOUNCEMENT INFO.;　Lung Cancer , 41, 179-186
  AUTHOR;　Wu S,Sato M,Endo C,Sakurada A,Dong B,Aikawa H,Chen Y,Okada Y,Matsumura Y,Sueoka E, and Kondo T.
  
• Hepatitis B and C viruses infection, lifestyle and genetic polymorphisms as risk factors for hepatocellular carcinoma in Haimen, China.;　2002/12
  ANNOUNCEMENT INFO.;　Jpn J Cancer Res, 93, 12, 1287-1292
  AUTHOR;　Yu SZ, Huang XE, Koide T, Cheng G, Chen GC, Harada K, Ueno Y, Sueoka E, Oda H, Tashiro F, Mizokami M, Ohno T, Xiang J, Tokudome S.
  
• Lung cancer prevention with (-)-epigallocatechin gallate using monitoring by heterogeneous nuclear ribonucleoprotein B1;　2002/06
  ANNOUNCEMENT INFO.;　Int J Oncol, 20, 6, 1233-9.
  AUTHOR;　Fujimoto N, Sueoka N, Sueoka E, Okabe S, Suganuma M, Harada M, Fujiki H.
  

Material, Commentary, Editorials, Research Report, A Comprehensive Journal Articles

• Monitoring of tumor cells by flow cytometry permits rapid evaluation of disease progression in monomorphic epitheliotropic intestinal T-cell lymphoma;　2021/07
  ANNOUNCEMENT INFO.;　Cytometry B Clin Cytom, 100, 4, 454-456
  AUTHOR;　Akihisa Umino, Yasushi Kubota, Miho Honda-Yoshigai, Tomomi Okazaki, Yurie Yoshihara, Kazuo Wakayama, Seiji Kawasaki, Kana Kusaba, Shinya Kimura, Eisaburo Sueoka
  
• A patient with antibody against low-frequency red blood cell antigen Co^b;　2020/07
  ANNOUNCEMENT INFO.;　Japanese Journal of Medical Technology, 69, 3, 445 - 450
  AUTHOR;　Mami NAKAO, Marie YAMADA, Naotomo YAMADA, Seiji KAWASAKI, Hideaki NAKAMURA, Yasushi KUBOTA, Shinya KIMURA, Eizaburo SUEOKA
  

General Lectures

• Correlation of strain classification with IR Biotyper and molecular epidemiological method of Pseudomonas aeruginosa;　2022/10
  ANNOUNCEMENT INFO.;　The 17th Congress of Asian Society for Clinical Pathology and Laboratory Medicine (ASCPaLM)(hybrid event), 2022,10, 7-9(On-site+Live streaming)
  AUTHOR;　Megumi Oho, Zenzo Nagasawa, Yumiko Funashima, Osamu Ueda, Shinya Watanabe, Longzhu Cui, Hiroshi Miyamoto, Eisaburo Sueoka
  
• P-1030.Biological significance of pyrimidine metabolism enzyme UCK2 of HTLV-1-infected cells in ATL leukemogenesis;　2022
  ANNOUNCEMENT INFO.;　The 81st Annual Meeting of the Japanese Cancer Association(), 2022, 9,29-10, 1(On-site/Live streaming), 2022, 9,27-10, 1,10,28-11,(On-demand), P3-2:HTLV-1
  AUTHOR;　○Tatsuro Watanabe, Hiroshi Ureshino, Hideaki Nakamura, Eisaburo Sueoka, Shinya Kimura
  
• Characteristics of circulating tumor DNA in lung cancer patients. ;　2019
  ANNOUNCEMENT INFO.;　AACR Annual Meeting 2019, 2019, 3, 29- 4, 3
  AUTHOR;　○Tomonori Abe, Chiho Nakashima, Akemi Sato, Yohei Harada, Eisaburo Sueoka, ShinyaKimura, NaokoAragane
  
• AnalysisofanovelvariantofHER2detectedbyclinicalsequencingin cancerofunknownprimary.;　2019
  ANNOUNCEMENT INFO.;　AACR Annual Meeting 2019, 2019, 3, 29- 4, 3
  AUTHOR;　○Yohei Harada, Tomomi Kashiwada, Akemi Sato, Tomonori Abe, Chiho nakashima, Eisaburo Sueoka, Shinya Kimura, Naoko Sueoka-Aragane.
  
• Investigation of origin of circulating free DNA: Is exosomal DNA the carrier?;　2018
  ANNOUNCEMENT INFO.;　AACR Annual Meeting 2018, 2018.4.14-18
  AUTHOR;　○Nakashima C, Abe T, Sato A, Nakamura T, Komiya K, Sueoka E, Kimura K, Sueoka-Aragane
  
• Characteristics of circulating tumor DNA in lung cancer patients.;　2018
  ANNOUNCEMENT INFO.;　AACR Annual Meeting 2018, 2018.4.14-18
  AUTHOR;　○Abe T, Nakashima C, Sato A, Sueoka E, Kimura K, Sueoka-Aragane N.
  
• Comprehensive approach for eradication of Adult T-cell Leukemia-　Lymphoma in Japan - prevention, translational research and clinical approach- ;　2018
  ANNOUNCEMENT INFO.;　The 14th Japan-Korea Joint Symposium on Cancer and Ageing Research, 2018.5.31-6.2
  AUTHOR;　Sueoka E, Nakamura H, Watanabe T, Sato A, Kimura S, Yamashita S, Ushijima T
  
• DEC plays a crucial role in DNA damage response via transcriptional regulation under hypoxic conditions;　2018
  ANNOUNCEMENT INFO.;　The 14th Japan-Korea Joint Symposium on Cancer and Ageing Research, 2018.5.31-6.2
  AUTHOR;　＊Tanimoto K, Nakamura H, Hirohashi N, Poellinger L, Sueoka E
  
• Investigation of origin of circulating free DNA: Is EV the carrier?;　2018
  ANNOUNCEMENT INFO.;　The 14th Japan-Korea Joint Symposium on Cancer and Ageing Research, 2018.5.31-6.2
  AUTHOR;　○Nakashima C, Sato A, Abe T, Nakamura T, Komiya K, Sueoka E, Kimura S, Sueoka-Aragane N.
  
• Characteristics of circulating tumor DNA in lung cancer patients. ;　2018
  ANNOUNCEMENT INFO.;　The 14th Japan-Korea Joint Symposium on Cancer and Ageing Research, 2018.5.31-6.2
  AUTHOR;　○Tomonori Abe, Chiho Nakashima, Yohei Harada, Akemi Sato, Eisaburo Sueoka, Shinya Kimura, Naoko Aragane.
  
• Characteristics of circulating free DNA in lung cancer patients. ;　2018
  ANNOUNCEMENT INFO.;　The 77th Annual Meeting of the Japanese Cancer Association, 2018.9.27-29
  AUTHOR;　○Tomonori Abe, Chiho Nakashima, Akemi Sato, Yohei Harada, Eisaburo Sueoka, Shinya Kimura, Naoko Aragane.
  
• Investigation of origin of circulating free DNA: Are extracellular vesicles the carrier?;　2018
  ANNOUNCEMENT INFO.;　The 77th Annual Meeting of the Japanese Cancer Association, 2018.9.27-29
  AUTHOR;　○Chiho Nakashima, Tomonori Abe, Yohei Harada, Akemi Sato, Tomomi Nakamura, Kazutoshi Komiya, Eisaburo Sueoka, Shinya Kimura, Naoko Sueoka-Aragane.
  
• Analysis of a novel mutation of ERBB2 in cancer of unknown primary;　2018
  ANNOUNCEMENT INFO.;　The 77th Annual Meeting of the Japanese Cancer Association, 2018.9.27-29
  AUTHOR;　○Yohei Harada, Tomomi Kashiwada, Akemi Sato, Tomonori Abe, Chiho nakashima, Eisaburo Sueoka, Shinya Kimura, Naoko Sueoka-Aragane.
  
• Abnormal CpG methylation around the transcription start sites as therapeutic target in adult-T cell leukemia-lymphoma;　2018
  ANNOUNCEMENT INFO.;　The 77th Annual Meeting of the Japanese Cancer Association, 2018.9.27-29
  AUTHOR;　○Tatsuro Watanabe, Hiroshi Uresino, Satoru Yamashita, Toshikazu Ushijima, Eisaburo Sueoka, Shinya Kimura
  
• CSCs in mouse skin carcinogenesis and inhibitory effects of EGCG on expression of stemness markers in human CSCs;　2018
  ANNOUNCEMENT INFO.;　The 77th Annual Meeting of the Japanese Cancer Association, 2018.9.27-29
  AUTHOR;　○Hirota Fujiki, Tatsuro Watanabe, Eisaburo Sueoka, Anchalee Rawangkan, Masami Suganuma
  
• Epigenetic regulation of the genes in indolent types of adult T-cell leukemia/lymphoma analyzed by comprehensive DNA methylation array;　2017
  ANNOUNCEMENT INFO.;　18th International Conference on Human Retrovirology HTLV and Related Viruses (HTLV 2017 Tokyo), 2017, 3, 7-10
  AUTHOR;　Nakamura H, Watanabe T, Sato A, Yamashita S, Ushijima T, Sueoka E
  
• Automatic DNA extraction system can improve the EGFR point mutation detection rate of liquid biopsy. ;　2017
  ANNOUNCEMENT INFO.;　AACR Annual Meeting 2017, 2017, 4, 1-5
  AUTHOR;　〇Nakashima C, Sato A, Abe T, Nakamura T, Komiya K, Sueoka E, Kimura K, Aragane N.
  
• Characteristics of cell free DNA in lung cancer patients. ;　2017
  ANNOUNCEMENT INFO.;　The 76th Annual Meeting of the Japanese Cancer Association, 2017, 9, 28-30
  AUTHOR;　〇Tomonori Abe, Chiho Nakashima, Naomi Watanabe, Akemi Sato, Eisaburo Sueoka, Shinya Kimura, Naoko Aragane.
  
• DNA extraction method using cellulose magnetic beads can improve the EGFR mutation detection rate.;　2017
  ANNOUNCEMENT INFO.;　The 76th Annual Meeting of the Japanese Cancer Association, 2017, 9, 28-30
  AUTHOR;　〇Chiho Nakashima, Tomonori Abe, Akemi Sato, Eisaburo Sueoka, Shinya Kimura, Naoko Aragane.
  
• Notch3 is regulated by Hypoxia-inducible factor-1a in hypoxia;　2016
  ANNOUNCEMENT INFO.;　The 13th Korea-Japan Joint Symposium on Helicobacter infection / The22nd Annual Meeting of the Japanese Society for Helicobacter Research (JSHR2016), 2016, 2, 24-26
  AUTHOR;　Hideaki Nakamura, Eisaburo Sueoka, Lorenz Poellinger
  
• Detection of left ventricular hypertrophy using electrocardiography in cases preidentified by echocardiography;　2016
  ANNOUNCEMENT INFO.;　The 32nd World Congress of Biomedical Laboratory Science (IFBLS 2016), 2016,8,31-9,4
  AUTHOR;　Maya Ishiguma, Toshiharu Umeki, Ichirou Tanabe, Taemi Akiyoshi, Takanori Higashitani, Eisaburo Sueoka
  
• Comparison of phage open reading flame typing and rep-PCR method for genetic typing of multi-drug resistant Pseudomonas aeruginosa strains;　2016
  ANNOUNCEMENT INFO.;　The 32nd World Congress of Biomedical Laboratory Science (IFBLS 2016), 2016,8,31-9,4
  AUTHOR;　Megumi Oho, Chinatsu Komatsu, Yusuke Hashimoto, Koji Kusaba, Takanori Higashitani, Zenzo Nagasawa, Hiroshi Miyamoto, Eisaburo Sueoka
  
• Functional analysis of Discoidin Domain Receptor 2(DDR2) mutation and expression in squamous cell lung cancer;　2016
  ANNOUNCEMENT INFO.;　107th Annial Meeting of theAmerican Association of Cancer Research (AACR Annual Meeting 2016), 2016, 4, 16-20
  AUTHOR;　○Naomi Kobayashi-Watanabe, Akemi Sato, Tatsuro Watanabe, Eisaburo Sueoka, Shinya Kimura, Naoko Sueoka-Aragane
  
• Immunological responses after massive blood transfusions after cardiovascular surgeries.;　2016
  ANNOUNCEMENT INFO.;　The 32nd World Congress of Biomedical Laboratory Science (IFBLS 2016), 2016, 8, 31-9, 4
  AUTHOR;　Yamada M, Yamada N, Nakao M, Higashitani T, Kubota Y, Kimura S, Sueoka E
  
• Inhibition of mammalian target of rapamycin by Torin2, an ATP-competitive inhibitor, induces growth inhibition in adult T cell leukemia;　2015
  ANNOUNCEMENT INFO.;　American Association for Cancer Research Annual Meeting 2015, 2015,4,18-22
  AUTHOR;　Watanabe T, Aragane N, Sueoka E
  
• Efficacy and toxicity of mogamulizumab for relapsed/refractory adult T-cell leukemia-lymphoma: a retrospective analysis in Saga prefecture, Japan. ;　2014
  ANNOUNCEMENT INFO.;　The 19th Congress of the European Hematology Association, 2014.6.12-15
  AUTHOR;　○Kamachi K, Kubota Y, Ureshino H, Miyahara M, Yoshihara M, Kitamura H, Ide M, Shindo T, Ando T, Kojima K, Sueoka E, Kimura S.
  
• 2-Hydroxypropyl-β-cyclodextrin acts as a novel anticancer agent. ;　2014
  ANNOUNCEMENT INFO.;　The 19th Congress of the European Hematology Association, 2014.6.12-15
  AUTHOR;　○Kubota Y, Yokoo M, Motoyama K, Higashi T, Taniyoshi M, Tokumaru H, Tabe Y, Mochinaga S, Sato A, Sueoka-Aragane N, Sueoka E, Arima H, Irie T, Kimura S.
  
• Monitoring of metastasis by detection of EGFR mutation, T790M, with plasma using animal model for metastasis of human lung cancer. ;　2014
  ANNOUNCEMENT INFO.;　AACR Annual Meeting 2014, 2014.4.5-9
  AUTHOR;　○Naoko Sueoka-Aragane, Akemi Sato, Naomi Kobayashi, Yumi Nagano, Eisaburo Sueoka, Seiji Okada, Shinya Kimura.
  
• Usefulness of peripheral blood for monitoring of acquired resistance to EGFR tyrosine kinase inhibitors in non-small cell lung cancer. ;　2014
  ANNOUNCEMENT INFO.;　AACR Annual Meeting 2014, 2014.4.5-9
  AUTHOR;　○Naomi Kobayashi, Naoko Sueoka-Aragane, Hitomi Umeguchi, Tomomi Nakamura, Akemi Sato, Kazutoshi Komiya, Yuji Takeda, Shinichiro Hayashi, Eisaburo Sueoka, Shinya Kimura.
  
• Diffuse bone marrow uptake of FDG in a patient with aleukemic acute lymphoblastic leukemia. ;　2014
  ANNOUNCEMENT INFO.;　The 5th JSH International Symposium 2014, 2014.5.24-25.
  AUTHOR;　○Hiroaki Kitamura, Toshihiko Ando, Kensuke Kojima, Kazuharu Kamachi, Mari Yoshihara, Takero Shindo, Yasushi Kubota, Kazutoshi Komiya, Naoko Sueoka-Aragane, Eizaburo Sueoka, Shinya Kimura.
  
• A partial E Ⅲ (EFM) patient with rare genotype expressing anti-E antibody after transfusion of platelet concentrates.;　2014
  ANNOUNCEMENT INFO.;　AABB Annual Meeting 2014, 2014.10.25-28
  AUTHOR;　Yamada M, Yamada N, Kon N, Miyazaki T, Ohasi W, Sato S, Higasitani T, Kubota Y, Takamoto S, Kimura S, Sueoka E
  
• Two cases of immune thrombocytopenic purpura with multiple cerebral microbleeds. ;　2014
  ANNOUNCEMENT INFO.;　The 76th Annual Meeting of the Japanese Society of Hematology, 2014.10.31－11.2
  AUTHOR;　○Hiroaki Kitamura, Mari Yoshihara, Kazuharu Kamachi, Makoto Eriguchi, Tomoyuki Noguchi, Yasushi Kubota, Takero Shindo, Toshihiko Ando, Eizaburo Sueoka, Kensuke Kojima, Shinya Kimura.
  
• 2-Hydroxypropyl-β-cyclodextrin acts as a novel anticancer agent. ;　2014
  ANNOUNCEMENT INFO.;　The 76th Annual Meeting of the Japanese Society of Hematology, 2014.10.31－11.2
  AUTHOR;　Yasushi Kubota, Masako Yokoo, Keiichi Motoyama, Taishi Higashi, Masatoshi Taniyoshi, Hiroko Tokumaru, Yoko Tabe, Eisaburo Sueoka, Hidetoshi Arima, Tetsumi Irie, Shinya Kimura.
  
• Establishment of a rapid and automated detection system for BRAF mutations in malignant melanoma;　2013
  ANNOUNCEMENT INFO.;　AACR Annual Meeting 2013, 2013,4,6-10
  AUTHOR;　Ide M, Koba Shinichi, Nagano Y, Aragane-Sueoka N, Sato A, Inoue T , Kobayashi N, Misago N, Narisawa Y, Kimura S, Sueoka E
  
• Development of animal model mimicking metastasis of human lung cancers using NOJ/SCID mice;　2013
  ANNOUNCEMENT INFO.;　AACR Annual Meeting 2013, 2013,4,6-10
  AUTHOR;　Sueoka-Aragane N, Sato A , Kobayashi Ni, Ide M, Sueoka E, Okada S, Kimura S
  
• Establishment of automated monitoring program for transfusional iron overload using electronic medical recording system.;　2013
  ANNOUNCEMENT INFO.;　EUROMEDLAB Milano 2013, 2013,5,19-23
  AUTHOR;　Sueoka Eisaburo, Yamada Naotomo, .; Marie, Yamada.; Yasushi, Kubota.; Shinya, Kimura
  
• Deferasirox in iron-overloaded patients with hematologic disease at Saga University Hospital;　2013
  ANNOUNCEMENT INFO.;　
  AUTHOR;　〇Abe O, Yoshihara M, Kubota Y, Sueoak E, Kamachi K, Kitamura H, Itamura H, Nishi M, Shindo T, Fukushima N, Hamasaki Y, Kimura S
  
• 10 cases of Mogamulizumab treatment for Adult T cell Leukemia in Saga prefecture.;　2013
  ANNOUNCEMENT INFO.;　
  AUTHOR;　〇Ureshino H, Miyahara M, Kamachi K, Yoshihara M, Kitamura H, Itamura H, Yoshimura M, Yokoo M, Ide M, Kubota Y, Shindo T, Fukushima N, Sueoka E, Kimura S
  
• Is there any environmental differences to the occurrence of CRBSI in hematological patients?;　2013
  ANNOUNCEMENT INFO.;　
  AUTHOR;　〇Kitamura H, Kubota Y, Kaneko Y, Kamachi K, Yoshihara M, Itamura H, Shindo T, Fukushima N, Ando T, Ichinohe T, Sueoka E, Aoki Y, Kimura S
  
• Mechanisms of resistance to EGFR tyrosine kinase inhibitors involving HER-family ligands and receptors;　2012
  ANNOUNCEMENT INFO.;　AACR Annual Meeting 2012, 2012.3.31-4.4
  AUTHOR;　＊Kentaro Iwanaga, Naoko Sueoka-Aragane, Akemi Sato, Tomomi Nakamura, Naomi Kobayashi, Eisaburo Sueoka, Shinya Kimura.
  
• Taylor made treatment using monitoring biomarkers for acquired resistance to molecular targeted therapy;　2012
  ANNOUNCEMENT INFO.;　Tumor Microenvironment Global Core Research Center Symposium Seoul, South Korea, 2012.8.23-24
  AUTHOR;　○Naoko Aragane, Akemi Sato, Kentaro Iwanaga, Naomi Kobayash, Shinya Kimura, Eisaburo Sueoka
  
• DNA dependent protein kinase as a new molecular target for treatment of non-small cell lung cancer;　2012
  ANNOUNCEMENT INFO.;　AACR Annual Meeting 2012, 2012.3.31-4.4
  AUTHOR;　○Naoko Aragane, Akemi Sato, Kentaro Iwanaga, Naomi Kobayash, Shinya Kimura, Eisaburo Sueoka.
  
• Co-existence of positive MET FISH status with EGFR mutations signifies poor prognosis in lung adenocarcinoma;　2012
  ANNOUNCEMENT INFO.;　AACR Annual Meeting 2012, 2012.3.31-4.4
  AUTHOR;　○Naomi Kobayashi, Naoko Aragane, Tomomi Nakamura, Akemi Sato, Yuji Takeda, Masahiro Mitsuoka, Fumio Yamasaki, Shinichiro Hayashi, Eisaburo Sueoka, Shinya Kimura.
  
• Application of MALDI-TOF MS-based strain typing for characterization of epidemiological relationships among bacterial atrains;　2012
  ANNOUNCEMENT INFO.;　12th Meeting of Asian Society of Clinical Pathology and Laboratory Medicine, 2012.11.29-12.1
  AUTHOR;　Megumi Oho, Zenzo Nagasawa, Koji Kusaba, Takanori Higashitani, Shoitiro Ohta, Eisaburo Sueoka, Hiroshi Miyamoto
  
• Coexistence of invasive cryptococcosis and mature B-cell neoplasm in an HIV-negative young adult;　2012
  ANNOUNCEMENT INFO.;　
  AUTHOR;　○Hidekazu Itamura，Takashi Hisatomi，Noriyasu Fukushima，Mariko Yoshimura，Masako Yokoo，Masaru Ide，Yasushi Kubota，Tatsuo Ichinohe，Mari Yoshihara，Masaki Nagata，Yousuke Aoki，Eisaburo Sueoka，Shinya Kimura
  
• Acute myeloid leukemia with t(3;8)(q26;q24) and monosomy 7 complicated by diabetes inspidus;　2012
  ANNOUNCEMENT INFO.;　
  AUTHOR;　○Yasushi Kubota，Tatsuo Ichinohe，Mariko Yoshimura，Hidekazu Itamura，Takashi Hisatomi，Noriyasu Fukushima，Eisaburo Sueoka，Miwako Matsuzaki，Masayuki Sano，Shinya Kimura
  
• DNA repair a molecular target of cancer prevention and treatment;　2008/11
  ANNOUNCEMENT INFO.;　韓国がん学会　　　　（教育講演） 2008/11/6
  AUTHOR;　○Sueoka E, Sueoka-Aragane N.
  
• hnRNP B1;a key modulator of DNA repair in carcinogenesis;　2008/11
  ANNOUNCEMENT INFO.;　韓国がん学会　　　　（シンポジウム） 2008/11/7
  AUTHOR;　○Sueoka E, Sueoka-Aragane N.
  
• NK314 as a new therapeutic agent of adult T cell leukemia;　2008
  ANNOUNCEMENT INFO.;　America Association for Cancer Research Annual Meeting　2008 4.12-16
  AUTHOR;　○Hisatomi T, Tomimasu R, Aragane N, Sato A, Komiya K, Okamoto K, Sueoka E,
  
• Inhibition of DNA repair system by hnRNP B1, an early detection marker for lung cancers, mediated through direct interaction with DNA-dependent protein kinase complex;　2007
  ANNOUNCEMENT INFO.;　American Association for Cancer Research Annual Meeting2007 Los Angels
  AUTHOR;　A Sato, N Sueoka, K Iwanaga, R Tomimasu, T Hisatomi, K Komiya, E Sueoka,
  
• Autoregulation of hnRNP A2/B1 gene promoter by hnRNP B1 protein, an early detection marker for lung cancer, and down regulation by DNA-PK complex in lung cancer cells.;　2007
  ANNOUNCEMENT INFO.;　American Association for Cancer Research Annual Meeting2007 Los Angels
  AUTHOR;　N Sueoka, A Sato, K Iwanaga, K Komiya, T Kuzu, E Sueoka
  
• 肺がん早期診断マーカーhnRNP B1によるhnRNP A2/B1プロモーターの自己制御;　2007
  ANNOUNCEMENT INFO.;　
  AUTHOR;　
  

Review Articles

• Cancer progression by the okadaic acid class of tumor promoters and endogenous protein inhibitors of PP2A, SET and CIP2A ;　2023/09
  ANNOUNCEMENT INFO.;　J Cancer Res Clin Oncol, 149, 11, 9425-9433
  AUTHOR;　Fujiki H, Sueoka E, Watanabe T, Komori A, Suganuma M
  
• Cancer progression by the okadaic acid class of tumor promoters and endogenous protein inhibitors of PP2A, SET and CIP2A;　2023/09
  ANNOUNCEMENT INFO.;　J Cancer Res Clin Oncol, 149, 11, 9425-9433
  AUTHOR;　Fujiki H, Sueoka E, Watanabe T, Komori A, Suganuma M
  
• Diagnostic Accuracy of FibroScan and Factors Affecting Measurements;　2020/11
  ANNOUNCEMENT INFO.;　Diagnostics (Basel), 10, 11, 940
  AUTHOR;　Satoshi Oeda, Kenichi Tanaka, Ayaka Oshima, Yasue Matsumoto, Eisaburo Sueoka, Hirokazu Takahashi
  
• The concept of the okadaic acid class of tumor promoters is revived in endogenous protein inhibitors of protein phosphatase 2A, SET and CIP2A, in human cancers.;　2018
  ANNOUNCEMENT INFO.;　J Cancer Res Clin Oncol. , 144, 12, 2339-2349
  AUTHOR;　〇Fujiki H, Sueoka E, Watanabe T, Suganuma M
  
• Cancer Prevention with Green Tea and Its Principal Constituent, EGCG: from Early Investigations to Current Focus on Human Cancer Stem Cells;　2018
  ANNOUNCEMENT INFO.;　Mol Cells. , 41, 2, 73-82
  AUTHOR;　〇Fujiki H, Watanabe T, Sueoka E, Rawangkan A, Suganuma M.
  

Invited Lecture, Special Lecture

• Liquid biopsy using circulating cell-free DNA as a powerful tool for monitoring tumor dynamics in clinical oncology;　2014
  ANNOUNCEMENT INFO.;　The 12th Japan-Korea Joint Symposium on Cancer and Ageing Research, 2014.6.19-21
  AUTHOR;　Eisaburo Sueoka
  
• The role of hypoxia inducible factors on maintenance of hematopoietic stem cells and leukemogenesis;　2012
  ANNOUNCEMENT INFO.;　Tumor Microenvironment Global Core Research Center Symposium Seoul, South Korea, 2012.8.23-24
  AUTHOR;　Eisaburo Sueoka, Masaru Ide, Naoko Sueoka-Aragane, Akemi Sato, Hideaki Nakamura, Yasushi Kubota, Shinya Kimura, Keiji Tanimoto
  
• Carcinogenesis mediated through hnRNP B1:Molecular target for early detection and treatment.;　2007
  ANNOUNCEMENT INFO.;　The 8th Japan-Korea Joint Symposium on Cancer and Ageing Research 岐阜
  AUTHOR;　E Sueoka
  
• Inhibition of Double-strand DNA Break Repair by hnRNP B1 Meddiated through interactionwith DNA-dependent Protein Kinase Complex in Adult T-cell Leukemia;　2007
  ANNOUNCEMENT INFO.;　13th Int’l Conference on Human Retrovirology HTLV and related VIRUSES 箱根
  AUTHOR;　E Sueoka, R Tomimasu, N Aragane, A Sato, T Hisatomi, K Komiya, N Fukushima, N Funai, N Kuwahara, M Ide